Skip to main content
M

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Filings indexed 1,110 across all filing types
Latest filing 2026-04-06 Regulatory Filings
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
MYX expects no material impact from US s232 tariffs 2 pages 175.8KB
Regulatory Filings
2026-04-06 English
Non-Executive Director retirement and recruitment 1
Regulatory Filings
2026-04-01 English
Ceasing to be a substantial holder 4 pages 196.5KB
Regulatory Filings
2026-03-30 English
Becoming a substantial holder 4 pages 268.5KB
Regulatory Filings
2026-03-26 English
Mayne Pharma ASX SMIDcaps conference presentation 18 pages 1.4MB
Regulatory Filings
2026-03-24 English
Becoming a substantial holder 3 pages 339.2KB
Regulatory Filings
2026-03-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.